The synthesis method of Polatuzumab vedotin
Polatuzumab vedotin is an antibody-drug conjugate comprising a monoclonal antibody against CD79b (a B cell receptor component) covalently conjugated to the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE) via a cleavable linker.
Jan 22，2024
